Nico Haller serves as a Director and Principal at KKR since September 2021, focusing on Healthcare Strategic Growth. In addition, Nico is a Board Member for Coriolis Pharma, Clinisupplies, Resolian, and Biosynth Carbosynth, holding these positions since March 2022, January 2023, July 2022, and October 2023, respectively. Previously, Nico was an Investment Executive and founding member at Aretex Capital Partners from April 2017 to September 2021, involved in Healthcare & Business Services. Prior experience includes working in Healthcare Investment Banking at Citi from June 2014 to March 2017 and serving as an Area Manager Trainee at ALDI SÜD between October 2009 and September 2012. Nico holds Master's Degrees in Business Administration from Ludwig-Maximilians-Universität München and Finance from emlyon business school, both obtained between 2012 and 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices